What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Dopamine
Michele Zoli mostly deals with Neuroscience, Nicotinic agonist, Receptor, Nicotinic acetylcholine receptor and Acetylcholine receptor.
Her Neuroscience research includes elements of Neurotransmission and Cell biology.
Her work carried out in the field of Nicotinic agonist brings together such families of science as Ventral tegmental area, Pharmacology and Nicotine.
The study incorporates disciplines such as Hippocampal formation, Dopaminergic, Dopamine and Neurodegeneration in addition to Nicotine.
Her research in Receptor intersects with topics in Endocrinology, Adenosine and Neuron.
In the subject of general Nicotinic acetylcholine receptor, her work in Ganglion type nicotinic receptor is often linked to Set, thereby combining diverse domains of study.
Her most cited work include:
- Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine (1160 citations)
- Brain nicotinic acetylcholine receptors : native subtypes and their relevance (686 citations)
- Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei (614 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Internal medicine, Endocrinology, Neuroscience, Nicotinic agonist and Central nervous system.
Her studies in Endocrinology integrate themes in fields like Neuropeptide and Neuropeptide Y receptor.
Her Neuroscience study combines topics in areas such as Receptor and Neurotransmission.
She combines subjects such as Acetylcholine receptor, Dopaminergic, Nicotine and Cell biology with her study of Nicotinic agonist.
Her study in Acetylcholine receptor is interdisciplinary in nature, drawing from both Protein subunit and Acetylcholine.
Michele Zoli works mostly in the field of Nicotine, limiting it down to topics relating to Pharmacology and, in certain cases, In vivo.
She most often published in these fields:
- Internal medicine (44.72%)
- Endocrinology (43.66%)
- Neuroscience (30.63%)
What were the highlights of her more recent work (between 2013-2021)?
- Neuroscience (30.63%)
- Nicotine (15.85%)
- Nicotinic agonist (20.42%)
In recent papers she was focusing on the following fields of study:
Michele Zoli focuses on Neuroscience, Nicotine, Nicotinic agonist, Cell biology and Pharmacology.
Michele Zoli has researched Neuroscience in several fields, including Synaptic plasticity and Long-term potentiation.
Her Nicotine research integrates issues from Nicotinic Receptors, Striatum, Brain stimulation reward and Receptor expression.
Her Nicotinic agonist study is related to the wider topic of Internal medicine.
Her Cell biology research is multidisciplinary, incorporating elements of Histone, Epigenetics and In vivo.
Her Oral administration study, which is part of a larger body of work in Pharmacology, is frequently linked to Cannabidiol, bridging the gap between disciplines.
Between 2013 and 2021, her most popular works were:
- Diversity of native nicotinic receptor subtypes in mammalian brain. (141 citations)
- Serum protein changes in a rat model of chronic pain show a correlation between animal and humans (86 citations)
- Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: focus on nicotine effects. (61 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
Neuroscience, Nicotinic agonist, Blood–brain barrier, Pharmacology and Nicotine are her primary areas of study.
Her study ties her expertise on microRNA together with the subject of Neuroscience.
Her study looks at the relationship between Nicotinic agonist and fields such as Acetylcholine receptor, as well as how they intersect with chemical problems.
Her Blood–brain barrier study also includes fields such as
- In vivo which is related to area like Cell, Endocytosis, Nanocarriers, Cell biology and Nanoparticles for drug delivery to the brain,
- Drug delivery which is related to area like Biophysics and Nanomedicine.
Her Pharmacology study integrates concerns from other disciplines, such as Amyloid beta, Senile plaques, Amyloid, Inflammation and Matrix metalloproteinase.
The Nicotine study combines topics in areas such as Glutamate receptor, Metabotropic glutamate receptor, Brain stimulation reward and Receptor expression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
